Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial
February 2025
Click for full info +Full Info:
Resource Type:
Journal Article
Journal Article
Resource
Citation:
Authors: Gengiah, T.N., Heck, C.J., Lewis, L., Mansoor, L.E., Harkoo, I., Myeni, N., Baum, M.M., Moss, J.A., Rooney, J.F., Hankins, C., Pozzetto, B., Abdool Karim, S.S., Abdool Karim, Q.
Health Risks(s):
- HIV
Product type(s):
- ARVs
- Implants
Topic(s):
- MPTs
- Reproductive Health
- Social
Region(s)
- Africa